Our study provides insight into the negative regulation of ISG expression by IFN-I and suggests the potential importance of PCGF3 in the diagnosis or treatment of clinical diseases, ranging from inflammatory to autoimmune diseases. The gene discussed is PCGF3; the disease is autoimmune disease.